Metabolic Technologies, Inc.

Part of MTI Biotech, Incorporated

UEI
Q3GFWSAJACN3
CAGE
47E83
Primary NAICS
541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
SAM.gov registration
Expired

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Subchapter S Corporation
Entity structure
Corporate Entity (Not Tax Exempt)
Corporate family
SAM.gov registration date

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Gamma-ketoaldehyde scavengers for alcoholic liver disease R43AA023715 National Institutes of Health $151,587
Sbir phase i: metabolic engineering of moritella marina MP-1 for DHA production 1248803 National Science Foundation $150,000
Nutritional intervention for age-related muscular function and strength losses R44AG034722 National Institute on Aging (NIH) $947,743

Quick answers

Is Metabolic Technologies, Inc. registered in SAM.gov?

Metabolic Technologies, Inc.'s SAM.gov registration expired on September 15, 2020.

What is Metabolic Technologies, Inc.'s most recent federal award?

Metabolic Technologies, Inc.'s most recent federal grant award is Gamma-ketoaldehyde scavengers for alcoholic liver disease (R43AA023715), from National Institutes of Health, on September 25, 2014.

On GovTribe

See Metabolic Technologies, Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login